FEATURED
FDA clears Viridian's veligrotug for TED as Lumvoa

Lumvoa (veligrotug-vvze) will launch immediately as he second FDA-approved TED treatment—and the first with labeling for both active and chronic TED.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Research